180 related articles for article (PubMed ID: 27120792)
1. Identification of lipid-phosphatidylserine (PS) as the target of unbiasedly selected cancer specific peptide-peptoid hybrid PPS1.
Desai TJ; Toombs JE; Minna JD; Brekken RA; Udugamasooriya DG
Oncotarget; 2016 May; 7(21):30678-90. PubMed ID: 27120792
[TBL] [Abstract][Full Text] [Related]
2. A comprehensive lipid binding and activity validation of a cancer-specific peptide-peptoid hybrid PPS1.
Desai TJ; Udugamasooriya DG
Biochem Biophys Res Commun; 2017 Apr; 486(2):545-550. PubMed ID: 28322795
[TBL] [Abstract][Full Text] [Related]
3. Identification of the minimum pharmacophore of lipid-phosphatidylserine (PS) binding peptide-peptoid hybrid PPS1D1.
Singh J; Shukla SP; Desai TJ; Udugamasooriya DG
Bioorg Med Chem; 2016 Sep; 24(18):4470-4477. PubMed ID: 27485601
[TBL] [Abstract][Full Text] [Related]
4. Unbiased Selection of Peptide-Peptoid Hybrids Specific for Lung Cancer Compared to Normal Lung Epithelial Cells.
Matharage JM; Minna JD; Brekken RA; Udugamasooriya DG
ACS Chem Biol; 2015 Dec; 10(12):2891-9. PubMed ID: 26509598
[TBL] [Abstract][Full Text] [Related]
5. A unique mid-sequence linker used to multimerize the lipid-phosphatidylserine (PS) binding peptide-peptoid hybrid PPS1.
Shukla SP; Manarang JC; Udugamasooriya DG
Eur J Med Chem; 2017 Sep; 137():1-10. PubMed ID: 28551176
[TBL] [Abstract][Full Text] [Related]
6. A mini-library system to investigate non-essential residues of lipid-phosphatidylserine (PS) binding peptide-peptoid hybrid PPS1.
Shukla SP; Udugamasooriya DG
Medchemcomm; 2017 Dec; 8(12):2208-2215. PubMed ID: 29527284
[TBL] [Abstract][Full Text] [Related]
7. Phosphatidylserine: A cancer cell targeting biomarker.
Sharma B; Kanwar SS
Semin Cancer Biol; 2018 Oct; 52(Pt 1):17-25. PubMed ID: 28870843
[TBL] [Abstract][Full Text] [Related]
8. Human lactoferricin derived di-peptides deploying loop structures induce apoptosis specifically in cancer cells through targeting membranous phosphatidylserine.
Riedl S; Leber R; Rinner B; Schaider H; Lohner K; Zweytick D
Biochim Biophys Acta; 2015 Nov; 1848(11 Pt A):2918-31. PubMed ID: 26239537
[TBL] [Abstract][Full Text] [Related]
9. In vitro and in vivo characterization of a combination chemotherapy formulation consisting of vinorelbine and phosphatidylserine.
Webb MS; Johnstone S; Morris TJ; Kennedy A; Gallagher R; Harasym N; Harasym T; Shew CR; Tardi P; Dragowska WH; Mayer LD; Bally MB
Eur J Pharm Biopharm; 2007 Mar; 65(3):289-99. PubMed ID: 17123800
[TBL] [Abstract][Full Text] [Related]
10. Essential role of phosphatidylserine externalization in apoptosing cell phagocytosis by macrophages.
Shiratsuchi A; Osada S; Kanazawa S; Nakanishi Y
Biochem Biophys Res Commun; 1998 May; 246(2):549-55. PubMed ID: 9610400
[TBL] [Abstract][Full Text] [Related]
11. Discovery of a phosphatidylserine-recognizing peptide and its utility in molecular imaging of tumour apoptosis.
Thapa N; Kim S; So IS; Lee BH; Kwon IC; Choi K; Kim IS
J Cell Mol Med; 2008; 12(5A):1649-60. PubMed ID: 18363834
[TBL] [Abstract][Full Text] [Related]
12. The antibiotic and DNA-transfecting peptide LAH4 selectively associates with, and disorders, anionic lipids in mixed membranes.
Mason AJ; Martinez A; Glaubitz C; Danos O; Kichler A; Bechinger B
FASEB J; 2006 Feb; 20(2):320-2. PubMed ID: 16352649
[TBL] [Abstract][Full Text] [Related]
13. Advantages of the phosphatidylserine-recognizing peptide PSP1 for molecular imaging of tumor apoptosis compared with annexin V.
Kim S; Bae SM; Seo J; Cha K; Piao M; Kim SJ; Son HN; Park RW; Lee BH; Kim IS
PLoS One; 2015; 10(3):e0121171. PubMed ID: 25803297
[TBL] [Abstract][Full Text] [Related]
14. A monoclonal antibody that binds anionic phospholipids on tumor blood vessels enhances the antitumor effect of docetaxel on human breast tumors in mice.
Huang X; Bennett M; Thorpe PE
Cancer Res; 2005 May; 65(10):4408-16. PubMed ID: 15899833
[TBL] [Abstract][Full Text] [Related]
15. Interaction of two antitumor peptides with membrane lipids - Influence of phosphatidylserine and cholesterol on specificity for melanoma cells.
Wodlej C; Riedl S; Rinner B; Leber R; Drechsler C; Voelker DR; Choi JY; Lohner K; Zweytick D
PLoS One; 2019; 14(1):e0211187. PubMed ID: 30682171
[TBL] [Abstract][Full Text] [Related]
16. Enhancing the potency of a whole-cell breast cancer vaccine in mice with an antibody-IL-2 immunocytokine that targets exposed phosphatidylserine.
Huang X; Ye D; Thorpe PE
Vaccine; 2011 Jun; 29(29-30):4785-93. PubMed ID: 21557977
[TBL] [Abstract][Full Text] [Related]
17. Effects of Pro --> peptoid residue substitution on cell selectivity and mechanism of antibacterial action of tritrpticin-amide antimicrobial peptide.
Zhu WL; Lan H; Park Y; Yang ST; Kim JI; Park IS; You HJ; Lee JS; Park YS; Kim Y; Hahm KS; Shin SY
Biochemistry; 2006 Oct; 45(43):13007-17. PubMed ID: 17059217
[TBL] [Abstract][Full Text] [Related]
18. Variation in human cancer cell external phosphatidylserine is regulated by flippase activity and intracellular calcium.
Vallabhapurapu SD; Blanco VM; Sulaiman MK; Vallabhapurapu SL; Chu Z; Franco RS; Qi X
Oncotarget; 2015 Oct; 6(33):34375-88. PubMed ID: 26462157
[TBL] [Abstract][Full Text] [Related]
19. Carfilzomib demonstrates broad anti-tumor activity in pre-clinical non-small cell and small cell lung cancer models.
Baker AF; Hanke NT; Sands BJ; Carbajal L; Anderl JL; Garland LL
J Exp Clin Cancer Res; 2014 Dec; 33(1):111. PubMed ID: 25612802
[TBL] [Abstract][Full Text] [Related]
20. Unbiased peptoid cell screen identifies a peptoid targeting newly appeared cell surface vimentin on tumor transformed early lung cancer cells.
Shukla SP; Zhang H; Fang B; Minna JD; Gomika Udugamasooriya D
Bioorg Med Chem; 2022 Mar; 58():116673. PubMed ID: 35189561
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
